US 12,324,430 B2
Topical antiseptic system
Dennie W. Dyer, Murrieta, CA (US); and John A. Garruto, Encinitas, CA (US)
Assigned to INFECTION CONTAINMENT COMPANY, LLC, Bradenton, FL (US)
Filed by INFECTION CONTAINMENT COMPANY, LLC, Bradenton, FL (US)
Filed on Jan. 25, 2022, as Appl. No. 17/583,964.
Application 16/567,660 is a division of application No. 15/189,709, filed on Jun. 22, 2016, abandoned.
Application 17/583,964 is a continuation of application No. 16/567,660, filed on Sep. 11, 2019, granted, now 11,259,521.
Claims priority of provisional application 62/327,736, filed on Apr. 26, 2016.
Claims priority of provisional application 62/200,900, filed on Aug. 4, 2015.
Claims priority of provisional application 62/183,059, filed on Jun. 22, 2015.
Prior Publication US 2022/0142154 A1, May 12, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A01N 25/24 (2006.01); A01N 25/10 (2006.01); A01N 33/12 (2006.01); A01N 37/44 (2006.01); A01N 59/12 (2006.01); A01N 65/00 (2009.01); A01N 65/08 (2009.01); A61K 8/20 (2006.01); A61K 8/41 (2006.01); A61K 8/44 (2006.01); A61K 8/73 (2006.01); A61K 8/90 (2006.01); A61K 9/00 (2006.01); A61K 31/14 (2006.01); A61K 31/198 (2006.01); A61K 31/79 (2006.01); A61K 33/18 (2006.01); A61K 45/06 (2006.01); A61K 47/10 (2017.01); A61K 47/18 (2017.01); A61Q 17/00 (2006.01); A61K 47/34 (2017.01); A61K 47/38 (2006.01); A61K 47/44 (2017.01)
CPC A01N 25/24 (2013.01) [A01N 25/10 (2013.01); A01N 33/12 (2013.01); A01N 37/44 (2013.01); A01N 59/12 (2013.01); A01N 65/00 (2013.01); A01N 65/08 (2013.01); A61K 8/20 (2013.01); A61K 8/416 (2013.01); A61K 8/44 (2013.01); A61K 8/731 (2013.01); A61K 8/90 (2013.01); A61K 9/0014 (2013.01); A61K 9/0043 (2013.01); A61K 31/14 (2013.01); A61K 31/198 (2013.01); A61K 31/79 (2013.01); A61K 33/18 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/183 (2013.01); A61K 47/186 (2013.01); A61Q 17/005 (2013.01); A61K 47/34 (2013.01); A61K 47/38 (2013.01); A61K 47/44 (2013.01); Y02A 50/30 (2018.01)] 17 Claims
 
1. A method of disinfecting skin of a subject comprising: prior to an invasive procedure,
applying directly to the skin of the subject an antiseptic composition comprising:
a first antimicrobial agent selected from the group consisting of I2, an iodophor, and a combination thereof, wherein the antimicrobial agent is present in an amount sufficient to provide an available iodine concentration of from about 0.25 wt-% or more to about 1.5 wt-% or less;
a second antimicrobial agent;
a nonionic or anionic surfactant;
a thickening agent comprising a nonionic cellulose derivative or nonionic copolymer, or combination thereof; and
water;
wherein:
said composition is free of any hydroxycarboxylic acid buffer and any fragrance; and
maintaining the antiseptic composition's contact on the skin during the procedure.